News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Cameron Health Appoints Kevin Hykes President and Chief Executive Officer

3/24/2010 8:38:51 AM

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Cameron Health, Inc. today announced the appointment of Kevin Hykes as the company's new President and Chief Executive Officer, effective March 23rd, 2010. Mr. Hykes has also been appointed to the company’s Board of Directors.

Cameron Health has developed the world’s first totally subcutaneous implantable defibrillator (the S-ICD® System) for the treatment of patients at risk of Sudden Cardiac Arrest (SCA).

"We are pleased to have Kevin joining the Cameron Health team at this critical juncture in our company's development," says Dr. William Link, Chairman of the Board at Cameron Health and Managing Director at Versant Ventures. "Cameron Health is making a very important transition from a development-stage organization to a company focused on the commercialization of the S-ICD System. Kevin's leadership capabilities, coupled with his knowledge of the ICD market, are critical to accelerating the growth of Cameron Health. We are also very grateful for the outstanding leadership that Jay Warren has provided to the Cameron Health team since 2002. Under his guidance, Cameron Health has achieved a number of significant technical milestones, and launched the only subcutaneous implantable defibrillator in the world."

Mr. Hykes joins Cameron Health from his most recent position as Chief Commercial Officer of Visiogen, Inc., a venture-backed ophthalmology company. Visiogen was acquired by Abbott Laboratories in October 2009. At Visiogen, Mr. Hykes was responsible for creating the global commercialization strategy for Visiogen and for establishing the company's business in Europe. Prior to joining Visiogen, Mr. Hykes spent 16 years at Medtronic where he held a number of senior management roles in the U.S. and Europe, including the Category Vice President of the company's defibrillation business, Vice President of Healthcare Systems and a member of Medtronic’s Operating Committee. Prior to joining Medtronic, Mr. Hykes spent three years as a consultant with Andersen Consulting in their Chicago office. Mr. Hykes also serves on the Board of Directors for Hansen Medical, Inc.

“I am excited to join the dedicated and talented Cameron Health team to bring this breakthrough product to patients and physicians worldwide. The S-ICD System is a novel technology that will reshape the treatment of Sudden Cardiac Arrest,” says Mr. Hykes.

About the S-ICD® System

Components of the Cameron Health S-ICD System include the SQ-RX™ Pulse Generator, Q-TRAK™ Subcutaneous Electrode, Q-GUIDE™ Electrode Insertion Tool and the Q-TECH™ Programmer. The S-ICD System is implanted subcutaneously (just under the skin) with the electrode running parallel and slightly to the left of the sternum. While most functions are automatic, adjustments and data retrieval can be easily achieved through a highly advanced integrated programming system developed specifically for the S-ICD System. The Q-TECH programmer is one of the smallest units in the industry weighing less than three pounds. The light weight, portable unit is capable of wireless communication with the SQ-RX Pulse Generator.

About Sudden Cardiac Arrest

Sudden Cardiac Arrest is a sudden, abrupt loss of heart function. Most SCA episodes are caused by the rapid and/or chaotic activity of the heart known as Ventricular Tachycardia or Ventricular Fibrillation. Recent estimates show that approximately 850,000 people in the U.S. are at risk of SCA and indicated for an ICD device, but remain unprotected. In fact, less than 35 percent of patients who are indicated for an ICD receive one. SCA is not the same as a heart attack. A heart attack is a malfunction caused by blockage in a vessel that supplies blood to the heart, which may permanently damage part of the heart. Unlike SCA, most people survive a first heart attack. SCA is an “electrical” malfunction of the heart that results in no blood flow to the body or the brain. SCA is fatal if left untreated. ICD’s are proven to be 98 percent effective in treating dangerous heart rhythms that can lead to SCA.

About Cameron Health, Inc.

Cameron Health, Inc. (, headquartered in San Clemente, California, is a pioneer in the development, manufacture and distribution of the next generation of implantable defibrillators.

Read at

comments powered by Disqus